{
    "nctId": "NCT02378337",
    "briefTitle": "Defining PET / CT Protocols With Optimized F18-FDG (Fluorodeoxyglucose) Dose, Focusing on Reduced Radiation Dose and Improved Image Quality",
    "officialTitle": "N/A",
    "overallStatus": "COMPLETED",
    "conditions": "Malignant Neoplasm of Breast, Hodgkin Disease, Non-Hodgkin Lymphoma, Follicular (Nodular), Malignant Neoplasm of Bronchus and Lung, Malignant Neoplasm of Colon, Secondary Neoplasm Malignant and Unspecified Lymph Nodes, Malignant Melanoma of the Skin, Malignant Neoplasm of Small Intestine",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 335,
    "primaryOutcomeMeasure": "Correlation of body weight with the variation coefficient (image noise).",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Healthy volunteers;\n* Both genders;\n* Age over 18 years;\n* Clinical indication for PET-CT scan.\n\nExclusion Criteria:\n\n* Pregnant women;\n* Patients who have lesions in the liver metabolically active whether primary or metastatic;\n* Patients with movement difficulties.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}